Literature DB >> 30677485

Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trial.

Heather M Johnson1, Lisa Sullivan-Vedder2, KyungMann Kim3, Patrick E McBride4, Maureen A Smith5, Jamie N LaMantia6, Jennifer T Fink7, Megan R Knutson Sinaise8, Laura M Zeller9, Diane R Lauver10.   

Abstract

Young adults (18-39 year-olds) with hypertension have a higher lifetime risk for cardiovascular disease. However, less than 50% of young adults achieve hypertension control in the United States. Hypertension self-management programs are recommended to improve control, but have been targeted to middle-aged and older populations. Young adults need hypertension self-management programs (i.e., home blood pressure monitoring and lifestyle modifications) tailored to their unique needs to lower blood pressure and reduce the risks and medication burden they may face over a lifetime. To address the unmet need in hypertensive care for young adults, we developed MyHEART (My Hypertension Education And Reaching Target), a multi-component, theoretically-based intervention designed to achieve self-management among young adults with uncontrolled hypertension. MyHEART is a patient-centered program, based upon the Self-Determination Theory, that uses evidence-based health behavior approaches to lower blood pressure. Therefore, the objective of this study is to evaluate MyHEART's impact on changes in systolic and diastolic blood pressure compared to usual care after 6 and 12 months in 310 geographically and racially/ethnically diverse young adults with uncontrolled hypertension. Secondary outcomes include MyHEART's impact on behavioral outcomes at 6 and 12 months, compared to usual clinical care (increased physical activity, decreased sodium intake) and to examine whether MyHEART's effects on self-management behavior are mediated through variables of perceived competence, autonomy, motivation, and activation (mediation outcomes). MyHEART is one of the first multicenter, randomized controlled hypertension trials tailored to young adults with primary care. The design and methodology will maximize the generalizability of this study. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03158051.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health behavior change; Health coaching; Hypertension; Randomized controlled trial; Self-management; Young adults

Mesh:

Substances:

Year:  2019        PMID: 30677485      PMCID: PMC6387836          DOI: 10.1016/j.cct.2019.01.010

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  188 in total

1.  Blood pressure measuring devices: recommendations of the European Society of Hypertension.

Authors:  E O'Brien; B Waeber; G Parati; J Staessen; M G Myers
Journal:  BMJ       Date:  2001-03-03

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

Authors:  D K Ahern; L Gorkin; J L Anderson; C Tierney; A Hallstrom; C Ewart; R J Capone; E Schron; D Kornfeld; J A Herd
Journal:  Am J Cardiol       Date:  1990-07-01       Impact factor: 2.778

4.  The ABCDs of Lifestyle Counseling.

Authors:  Andrew L Lehr; Steven L Driver; Neil J Stone
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

5.  Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension.

Authors:  B M Mehos; J J Saseen; E J MacLaughlin
Journal:  Pharmacotherapy       Date:  2000-11       Impact factor: 4.705

6.  Outpatient blood pressure monitoring using bi-directional text messaging.

Authors:  Chris A Anthony; Linnea A Polgreen; James Chounramany; Eric D Foster; Christopher J Goerdt; Michelle L Miller; Manish Suneja; Alberto M Segre; Barry L Carter; Philip M Polgreen
Journal:  J Am Soc Hypertens       Date:  2015-01-21

7.  The effect of a physical activity intervention on bias in self-reported activity.

Authors:  Daniel R Taber; June Stevens; David M Murray; John P Elder; Larry S Webber; Jared B Jobe; Leslie A Lytle
Journal:  Ann Epidemiol       Date:  2009-02-20       Impact factor: 3.797

8.  A shortened instrument for literacy screening.

Authors:  Pat F Bass; John F Wilson; Charles H Griffith
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

9.  Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women.

Authors:  K A Matthews; S F Kelsey; E N Meilahn; L H Kuller; R R Wing
Journal:  Am J Epidemiol       Date:  1989-06       Impact factor: 4.897

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  2 in total

1.  Factors influencing the self-management of kidney transplant patients based on self-determination theory: a cross-sectional study.

Authors:  Mi Kyung Sim; Sun Young Son; Man Ki Ju
Journal:  Korean J Transplant       Date:  2022-03-31

Review 2.  Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group.

Authors:  Holly C Gooding; Samuel S Gidding; Andrew E Moran; Nicole Redmond; Norrina B Allen; Fida Bacha; Trudy L Burns; Janet M Catov; Michael A Grandner; Kathleen Mullan Harris; Heather M Johnson; Michaela Kiernan; Tené T Lewis; Karen A Matthews; Maureen Monaghan; Jennifer G Robinson; Deborah Tate; Kirsten Bibbins-Domingo; Bonnie Spring
Journal:  J Am Heart Assoc       Date:  2020-09-30       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.